Profile

Kasia McCartney is a PhD candidate in Integrative Medicine and Applied Psychophysiology with a profound interest in psychoneuroimmunology, epigenetics, and holistic, neurophysiologically-informed therapies. Based in Edinburgh, she is the founder of Encephalon, a pioneering neurotechnology practice where she integrates multiple Brain-Computer Interface (BCI) systems to support individuals with developmental and neurological disorders.

Her clinical work focuses on neurofeedback and cutting-edge neurotechnologies, addressing conditions such as ADHD, Autism Spectrum Disorder, and Functional Neurological Disorder (FND). She is currently working with a large population of individuals diagnosed with Motor Neuron Disease (MND), applying BCI-based interventions aimed at restoring motor function and enhancing quality of life.

Kasia is also engaged in ongoing research exploring the neural correlates of alexithymia—particularly its relevance to FND and emotion regulation. Her academic work aims to bridge the gap between emerging neuroscience and real-world clinical applications, highlighting the intricate connections between emotional processing, brain function, and somatic symptoms.

An experienced educator and speaker, Kasia regularly delivers training and lectures on the efficacy of neurofeedback and integrative approaches to neurodevelopmental and neurological conditions. She is scheduled to present at the upcoming Annual Neuroscience and Psychiatry Conference, where she will discuss Functional Neurological Disorder and Psychogenic Non-Epileptic Seizures (PNES), contributing to a growing interdisciplinary dialogue around mind-body medicine.

Through her research, clinical innovation, and educational outreach, Kasia is dedicated to advancing compassionate, science-backed care that empowers individuals and supports long-term wellbeing.